Novel MCG Cardiac Imaging Device v1.0

  • Research type

    Research Study

  • Full title

    Two cohort, pilot study, to identify magnetocardiogram characteristics that can be used to classify non ischaemic chest pain patients and myocardial infarction patients.

  • IRAS ID

    157970

  • Contact name

    Cassandra Doherty

  • Contact email

    cassie.doherty@quantumimaging.eu

  • Sponsor organisation

    Quantum Imaging Limited

  • Duration of Study in the UK

    0 years, 3 months, 1 days

  • Research summary

    Magnetocardiography is a passive, non-contact technique to measure the electromagnetic activity of the heart. This electromagnetic activity can give useful functional information about the heart.
    The existing technology used for magnetocardiography are SQUID magnetocardiogram (MCG)devices, but the use of these devices has been limited by their high cost, requirement for liquid helium cooling, need for a shielded room and large size. They have been widely deployed for research but are not utilised routinely in clinical care.
    Quantum Imaging is developing a portable MCG device that has no requirement for specialist cooling, no need for a shielded room and can therefore be used in any clinical environment.
    The Quantum Imaging technology has the potential to be used to determine if an individual has a healthy heart or has suffered from a myocardial infarction (heart attack) (MI). There is a strong healthcare need for technologies to help the triage of patients presenting to the emergency department (ED) with chest pain. Around 80% of patients who present have not had an MI, but still need to follow the standard care pathway. This pathway requires a biomarker test (troponin) taken at 12 hours after the onset of chest pain as a MI rule in test. A technology that can rapidly determine the healthy status of a patient would improve the cost effectiveness of the care pathway and improve the patient experience.
    This purpose of this study is to collect MCG data from subjects with non ischemic chest pain, and those who have had an MI. Using these data it will be possible to determine the characteristics of the MCG scan that correlate with a patient with non ischemic chest pain and an MI patient. These data from this pilot study will be used to power future studies and as a tool to classify MCG scans.

  • REC name

    Yorkshire & The Humber - Leeds East Research Ethics Committee

  • REC reference

    14/YH/1222

  • Date of REC Opinion

    5 Dec 2014

  • REC opinion

    Further Information Favourable Opinion